Faeth Therapeutics, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | -34.2% | +1,660.7% | +615.1% | -22.7% | -37.2% | -39.0% | -49.5% | |
| – | -60.8% | +3,899.2% | +639.9% | -26.9% | -38.1% | -37.7% | -48.7% | |
| – | -61.6% | +6,512.0% | -56.9% | +148.6% | -26.9% | -23.2% | -13.3% | |
| – | -61.6% | +6,512.0% | +789.5% | -27.4% | -38.6% | -37.1% | -48.8% | |
| – | +26.3% | -92.1% | +21.3% | +123.0% | -36.7% | -26.4% | -38.2% | |
| – | +715.4% | -77.8% | +1.2% | +85.4% | -37.8% | -3.5% | -22.0% | |
| – | +2,206.8% | -99.8% | +2,025.0% | +213.4% | +14.5% | -5.0% | -37.4% | |
| – | +211.5% | +12.5% | -36.7% | +82.1% | -62.1% | -85.6% | +182.4% | |
| – | – | – | +821.9% | -29.4% | -37.2% | -40.8% | -51.6% | |
| – | – | – | – | – | – | – | – | |
| – | +0.0% | +4.3% | -9.4% | +10.8% | -9.0% | -10.1% | +0.4% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.